BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 22519443)

  • 21. Matrix metalloproteinases.
    Vargová V; Pytliak M; Mechírová V
    Exp Suppl; 2012; 103():1-33. PubMed ID: 22642188
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Matrix metalloproteinases: regulation and dysregulation in the failing heart.
    Spinale FG
    Circ Res; 2002 Mar; 90(5):520-30. PubMed ID: 11909815
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Membrane-associated matrix proteolysis and heart failure.
    Spinale FG; Janicki JS; Zile MR
    Circ Res; 2013 Jan; 112(1):195-208. PubMed ID: 23287455
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Regulation of Myocardial Extracellular Matrix Dynamic Changes in Myocardial Infarction and Postinfarct Remodeling.
    Ushakov A; Ivanchenko V; Gagarina A
    Curr Cardiol Rev; 2020; 16(1):11-24. PubMed ID: 31072294
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Mechanisms of extracellular matrix remodeling in dilated cardiomyopathy].
    Pauschinger M; Chandrasekharan K; Li J; Schwimmbeck PL; Noutsias M; Schultheiss HP
    Herz; 2002 Nov; 27(7):677-82. PubMed ID: 12439639
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Matrix metalloproteinases: pathways of induction by bioactive molecules.
    Tsuruda T; Costello-Boerrigter LC; Burnett JC
    Heart Fail Rev; 2004 Jan; 9(1):53-61. PubMed ID: 14739768
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Structure and Function of Human Matrix Metalloproteinases.
    Laronha H; Caldeira J
    Cells; 2020 Apr; 9(5):. PubMed ID: 32357580
    [TBL] [Abstract][Full Text] [Related]  

  • 28. How could analyzing the activity of two matrix metalloproteinases unveil the cause of sudden cardiac death.
    Sosa I; Grubesic A
    Int J Immunopathol Pharmacol; 2016 Dec; 29(4):712-714. PubMed ID: 27271976
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Biochemical and Biological Attributes of Matrix Metalloproteinases.
    Cui N; Hu M; Khalil RA
    Prog Mol Biol Transl Sci; 2017; 147():1-73. PubMed ID: 28413025
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Matrix metalloproteinases in atherothrombosis.
    Bäck M; Ketelhuth DF; Agewall S
    Prog Cardiovasc Dis; 2010; 52(5):410-28. PubMed ID: 20226959
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Matrix metalloproteinases in vascular physiology and disease.
    Siefert SA; Sarkar R
    Vascular; 2012 Aug; 20(4):210-6. PubMed ID: 22896663
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Extracellular degradative pathways in myocardial remodeling and progression to heart failure.
    Spinale FG; Gunasinghe H; Sprunger PD; Baskin JM; Bradham WC
    J Card Fail; 2002 Dec; 8(6 Suppl):S332-8. PubMed ID: 12555141
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Involvement of matrix metalloproteinases in the regulation of myocardial extracellular matrix in patients with congestive heart failure].
    Yang YJ; Zhang X; Zhu WL; Huang Y
    Zhonghua Yi Xue Za Zhi; 2006 Jun; 86(24):1693-6. PubMed ID: 16854324
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Loss of PI3Kγ enhances cAMP-dependent MMP remodeling of the myocardial N-cadherin adhesion complexes and extracellular matrix in response to early biomechanical stress.
    Guo D; Kassiri Z; Basu R; Chow FL; Kandalam V; Damilano F; Liang W; Izumo S; Hirsch E; Penninger JM; Backx PH; Oudit GY
    Circ Res; 2010 Nov; 107(10):1275-89. PubMed ID: 20847309
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The role of changes of matrix metalloproteinase in cardiovascular diseases].
    Gasanov AG; Bershova TV
    Biomed Khim; 2009; 55(2):155-68. PubMed ID: 19507339
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relevance of matrix metalloproteinases and their inhibitors after myocardial infarction: a temporal and spatial window.
    Vanhoutte D; Schellings M; Pinto Y; Heymans S
    Cardiovasc Res; 2006 Feb; 69(3):604-13. PubMed ID: 16360129
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Myocardial remodeling in viral heart disease: possible interactions between inflammatory mediators and MMP-TIMP system.
    Pauschinger M; Chandrasekharan K; Schultheiss HP
    Heart Fail Rev; 2004 Jan; 9(1):21-31. PubMed ID: 14739765
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bioactive peptide signaling within the myocardial interstitium and the matrix metalloproteinases.
    Spinale FG
    Circ Res; 2002 Dec; 91(12):1082-4. PubMed ID: 12480806
    [No Abstract]   [Full Text] [Related]  

  • 39. Development of Matrix Metalloproteinases-Mediated Extracellular Matrix Remodeling in Regenerative Medicine: A Mini Review.
    Chen K; Xu M; Lu F; He Y
    Tissue Eng Regen Med; 2023 Aug; 20(5):661-670. PubMed ID: 37160567
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Implications of myocardial matrix remodeling by adipokines in obesity-related heart failure.
    Schram K; Sweeney G
    Trends Cardiovasc Med; 2008 Aug; 18(6):199-205. PubMed ID: 19185809
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.